Validation of a GATA2 methylation and FGFR3 mutation assay to predict progression in BCG-treated high-risk non-muscle-invasive bladder cancer

Saved in:
Bibliographic Details
Published in:European urology open science (Online) 2022-11, Vol.45, p.S255-S256
Main Authors: Olislagers, M., De Jong, F.C., Van Etten, V.M.J., Kan, T.W., Zuiverloon, T.C.M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2666-1683
2666-1683
DOI:10.1016/S2666-1683(22)02592-7